Nicholas Morley

2.5k total citations
75 papers, 1.5k citations indexed

About

Nicholas Morley is a scholar working on Pathology and Forensic Medicine, Aerospace Engineering and Oncology. According to data from OpenAlex, Nicholas Morley has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 16 papers in Aerospace Engineering and 13 papers in Oncology. Recurrent topics in Nicholas Morley's work include Lymphoma Diagnosis and Treatment (16 papers), Nuclear reactor physics and engineering (12 papers) and Nuclear Materials and Properties (10 papers). Nicholas Morley is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Nuclear reactor physics and engineering (12 papers) and Nuclear Materials and Properties (10 papers). Nicholas Morley collaborates with scholars based in United Kingdom, United States and Australia. Nicholas Morley's co-authors include Elizabeth M. Baggs, Tim J. Daniell, Madeline Giles, Eric Paterson, Lars R. Bakken, David P. Wall, Mohamed S. El‐Genk, John Aldridge, Mark Trimmer and Christian A. Davies and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Nicholas Morley

66 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Morley United Kingdom 18 600 398 345 304 254 75 1.5k
Yingying Ye China 24 466 0.8× 424 1.1× 90 0.3× 176 0.6× 213 0.8× 159 2.0k
Zhifeng Yan China 22 369 0.6× 326 0.8× 255 0.7× 123 0.4× 193 0.8× 102 2.0k
Shengping Li China 29 845 1.4× 260 0.7× 175 0.5× 51 0.2× 288 1.1× 70 2.4k
Bahram Momen United States 22 105 0.2× 148 0.4× 167 0.5× 63 0.2× 279 1.1× 65 2.2k
Daoyuan Wang China 23 551 0.9× 118 0.3× 91 0.3× 209 0.7× 230 0.9× 81 1.8k
Eric A. Strauss United States 21 135 0.2× 660 1.7× 854 2.5× 289 1.0× 46 0.2× 39 1.6k
Xinsheng Chen China 28 209 0.3× 1.1k 2.7× 386 1.1× 87 0.3× 476 1.9× 138 2.6k
Mingxu Li China 24 384 0.6× 577 1.4× 253 0.7× 55 0.2× 318 1.3× 152 2.3k
Mingxiang Zhang China 27 344 0.6× 747 1.9× 207 0.6× 178 0.6× 336 1.3× 96 1.7k
Yu Hu China 20 211 0.4× 461 1.2× 102 0.3× 44 0.1× 107 0.4× 71 1.4k

Countries citing papers authored by Nicholas Morley

Since Specialization
Citations

This map shows the geographic impact of Nicholas Morley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Morley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Morley more than expected).

Fields of papers citing papers by Nicholas Morley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Morley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Morley. The network helps show where Nicholas Morley may publish in the future.

Co-authorship network of co-authors of Nicholas Morley

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Morley. A scholar is included among the top collaborators of Nicholas Morley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Morley. Nicholas Morley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trněný, Marek, Abraham Avigdor, Matthew McKinney, et al.. (2023). Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study. EClinicalMedicine. 63. 102130–102130. 3 indexed citations
2.
Thompson, Luke, et al.. (2023). E018 COVID-19 vaccine-induced myositis. Lara D. Veeken. 62(Supplement_2).
3.
Morley, Nicholas, et al.. (2023). Impact of formaldehyde, acetaldehyde, and N-(3-(Dimethylamino)propyl)methacrylamide on the efficacy of the human derived coagulation factor IX. International Journal of Pharmaceutics. 634. 122664–122664.
4.
5.
Pearce, Rachel, Julia Perry, Keiren Kirkland, et al.. (2020). Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma—a retrospective study from the BSBMT (BEAM versus LEAM). Bone Marrow Transplantation. 56(3). 730–732. 3 indexed citations
6.
Katz, Deborah A., Michael P. Chu, Kevin A. David, et al.. (2019). Open-Label, Phase 2 Study of Blinatumomab after First-Line Rituximab-Chemotherapy in Adults with Newly Diagnosed, High-Risk Diffuse Large B-Cell Lymphoma. Blood. 134(Supplement_1). 4077–4077. 20 indexed citations
7.
Thomas, Sally, Nicholas Morley, Hany Lashen, Kikkeri N. Naresh, & Malee Fernando. (2019). Indolent T-Cell Lymphoproliferative Disorder of the Uterine Corpus: A Case Report. International Journal of Gynecological Pathology. 39(5). 503–506. 1 indexed citations
8.
Maheswaran, Ravi & Nicholas Morley. (2018). Incidence, socioeconomic deprivation, volume-outcome and survival in adult patients with acute lymphoblastic leukaemia in England. BMC Cancer. 18(1). 25–25. 6 indexed citations
9.
Rule, Simon, Gordon Cook, Nigel H. Russell, et al.. (2018). Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. British Journal of Haematology. 184(6). 999–1005. 25 indexed citations
10.
Tappenden, Paul, Emma Simpson, Jean Hamilton, et al.. (2018). Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(3). 333–343. 2 indexed citations
11.
Diem, Torsten, Nicholas Morley, Elizabeth M. Baggs, et al.. (2017). Complex controls on nitrous oxide flux across a large-elevation gradient in the tropical Peruvian Andes. Biogeosciences. 14(22). 5077–5097. 5 indexed citations
12.
Morley, Nicholas & D I Marks. (2015). Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia. Expert Review of Anticancer Therapy. 16(2). 159–164. 5 indexed citations
13.
Teh, Yit Arn, Torsten Diem, Sam P. Jones, et al.. (2014). Methane and nitrous oxide fluxes across an elevation gradient in the tropical Peruvian Andes. Biogeosciences. 11(8). 2325–2339. 29 indexed citations
14.
Teh, Yit Arn, Torsten Diem, Elizabeth M. Baggs, et al.. (2013). Methane and nitrous oxide fluxes from the tropical Andes. Edinburgh Research Explorer. 4 indexed citations
15.
Giles, Madeline, Nicholas Morley, Elizabeth M. Baggs, & Tim J. Daniell. (2012). Soil nitrate reducing processes – drivers, mechanisms for spatial variation, and significance for nitrous oxide production. Frontiers in Microbiology. 3. 407–407. 210 indexed citations
16.
Morley, Nicholas, et al.. (2008). Production of NO, N2O and N2 by extracted soil bacteria, regulation by NO2â and O2 concentrations. FEMS Microbiology Ecology. 65(1). 102–112. 138 indexed citations
17.
Selcuk, Cem, Nicholas Morley, & J. V. Wood. (2005). Densification of porous tungsten by low temperature sintering. Powder Metallurgy. 48(3). 245–248. 2 indexed citations
18.
Selcuk, Cem, Nicholas Morley, & J. V. Wood. (2005). Porous tungsten with controlled porosity by low temperature sintering. Powder Metallurgy. 48(1). 17–22. 5 indexed citations
19.
Stengel, Dagmar B., Ailbhe Macken, Liam Morrison, & Nicholas Morley. (2003). Zinc concentrations in marine macroalgae and a lichen from western Ireland in relation to phylogenetic grouping, habitat and morphology. Marine Pollution Bulletin. 48(9-10). 902–909. 73 indexed citations
20.
El‐Genk, Mohamed S., et al.. (1990). Preliminary assessment of the power requirements of a manned rover for Mars missions. 1278–1287. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingying Ye Breakdown of academic impact, for papers by Zhifeng Yan Breakdown of academic impact, for papers by Shengping Li Breakdown of academic impact, for papers by Bahram Momen Breakdown of academic impact, for papers by Daoyuan Wang Breakdown of academic impact, for papers by Eric A. Strauss Breakdown of academic impact, for papers by Xinsheng Chen Breakdown of academic impact, for papers by Mingxu Li Breakdown of academic impact, for papers by Mingxiang Zhang Breakdown of academic impact, for papers by Yu Hu
Rankless by CCL
2026